PREDICTABLE HATCHET JOB AGAINST IVERMECTIN BY THE NEW YORK TIMES

The latest issue of the New England Journal of Medicine has published a "randomised trial" from Brazil on ivermectin treatment for Covid 19 patients.

The paper predictably is full of holes and thats probably the reason the NEJM has published it.

Astonishingly no American journalist, podcaster, or media person has bothered to interview any Indian physician regarding the efficacy of ivermectin in treatment of patients infected with SARS-CoV-2.

This is against the background that millions of Covid patients have been successfully treated with Ivermectin in India.

This attitude can only be explained by conceit or an obnoxious sense of misplaced superiority.